Advances In Transient Receptor Potential Vanilloid-2 Channel Expression And Function In Tumor Growth And Progression

ISSN: 1875-5550 (Online)
ISSN: 1389-2037 (Print)


Volume 15, 8 Issues, 2014


Download PDF Flyer




Current Protein & Peptide Science

Aims & ScopeAbstracted/Indexed in


Submit Abstracts Online Submit Manuscripts Online

Editor-in-Chief:
Ben M. Dunn
Department of Biochemistry and Molecular Biology University of Florida
College of Medicine, P.O. Box 100245, Gainesville
Florida, FL 32610-0245
USA


View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Current: 2.328
5 - Year: 3.031

Advances In Transient Receptor Potential Vanilloid-2 Channel Expression And Function In Tumor Growth And Progression

Author(s): Sonia Liberati, Maria Beatrice Morelli, Consuelo Amantini, Matteo Santoni, Massimo Nabissi, Claudio Cardinali and Giorgio Santoni

Affiliation: School of Pharmacy, Experimental Medicine Section, University of Camerino, Via Madonna delle Carceri, 9 62032, Camerino (MC), Italy

Abstract

We evaluate the involvement of TRPV2 channel, belonging to the Transient Receptor Potential Vanilloid channel family (TRPVs), in the progression of different tumor types. In normal cells, the activation of TRPV2 by growth factors, hormones and endocannabinoids induces its translocation from the endosomal compartment to the plasma membrane, which results in abrogation of cell proliferation and induction of cell death. Consequently, loss or inactivation of TRPV2 signaling induces unchecked proliferation, resistance to apoptotic signals. On the other hand, in prostate cancer cells, Ca2+-dependent activation of TRPV2 induced by lysophospholipids and adrenomedullin, increases migration and invasion of tumor cells. The progression of prostate cancer to the castration-resistant phenotype requires de novo TRPV2 expression, with higher TRPV2 transcript levels in patients with metastatic cancer. Finally, TRPV2 functional expression in tumor cells can also depend on the presence of alternative splice variants of TRPV2 mRNA that acts as dominant negative mutant of wild-type TRPV2 channels, by inhibiting its trafficking and translocation to the plasma membrane. Thus, in bladder cancer tumors, loss or reduction of a short TRPV2 variant during cancer progression is associated with the acquisition of an invasive phenotype and a malignant behaviour. High expression of TRPV2 was observed more frequently in esophageal squamous cell carcinoma patients with advanced pT stage, lymph node metastasis and advanced pathological stage. In conclusion, as TRP channels are altered in human cancer, and their blockade impairs the neoplastic progression, they appear to be a very promising target for tumor diagnosis and therapy

Keywords: Bladder carcinoma, Esophageal squamous cell carcinoma, Glioblastoma, Hepatocarcinoma, Prostate cancer, Transient Receptor Potential channels, Transient Receptor Potential Vanilloid-type 2, Tumor progression

Purchase Online Rights and Permissions

  
  



Article Details

Volume: 15
First Page: 1
Last Page: 6
Page Count: 6
DOI: 10.2174/1389203715666140704115913
Advertisement

Related Journals



Webmaster Contact: urooj@benthamscience.org Copyright © 2014 Bentham Science